A radiopharmaceutical consisting of a sulfonamide covalently attached to the positron-emitting isotope fluorine F 18 with CA-IX-binding and radioisotopic activities. Upon administration, the sulfonamide moiety of [F18]VM4-037 binds to the cell-surface tumor-associated antigen (TAA) carbonic anhydrase IX isoenzyme (CA-IX); CA-IX-expressing tumor cells can then be visualized using positron emission tomography (PET). CA-IX has been found to be elevated in a variety of hypoxic tumors; elevated CA-IX has been positively correlated with tumor growth, tumor invasion and poor prognosis.
Dictionary of pharmaceutical drugs/medications sorted alphabetically
- A 1 | A 2 | A 3 | B | C | C1 | C2
- D | E | F | G | H | I | J
- K | L | M | M 2 | N | O | P | Q
- R | S | S page 2 | T | U
- V | W | X | Y | Z | 0 - 9
Articles on (F18)VM4-037
Learn more about (F18)VM4-037
Find something you can improve? Join WikiMD as an an editor and help improve this page or others.